Semaglutide 30mg
Semaglutide
Semaglutide is a GLP-1 receptor agonist research peptide. The 30mg variant offers extended supply for long-duration research protocols. Widely investigated in models of obesity and metabolic resistance.
For Research Use Only
Not for human consumption, veterinary use, or any therapeutic applications.
Purity
Purity Exceeds 99%
Storage
36-46°F (2-8°C)
Origin
Made in USA
Documentation
COA Available
Procurement Information
This product is available exclusively to qualified research institutions and licensed facilities through authorized distribution channels.
- Valid research credentials required
- Orders processed through authorized agents only
- End-user certification documentation required
Research Mechanisms
- GLP-1 receptor agonist
- Glucose-dependent insulin secretion regulation
- Central appetite suppression via hypothalamic signaling
- Gastric emptying modulation
- Glucagon secretion inhibition
Research Background
- Extensively studied in obesity and metabolic resistance models
- Basis for FDA-approved Ozempic and Wegovy formulations
- SUSTAIN and STEP clinical trial series
- Research into cardiovascular risk reduction
Storage & Handling
Recommended Storage Conditions
Store at 36–46°F (2–8°C). Protect from light. Do not freeze.
- - Keep away from direct sunlight
- - Maintain consistent temperature
- - Check expiration date before use
- - Reconstituted peptides: use within 28 days

